XNYS · Healthcare Plans
Last stored close · Sep 18, 2026
Close · Sep 18, 2026
$376.90+0.45%
Model Target
available with Pro
Implied upside
vs the model target
Valuation methods
the methods behind the target
TickerWhale Score
48/100
Moderate
Score components
TickerWhale View
Unitedhealth Group scores 48 out of 100 overall, which we rate moderate. Quality & growth is its strongest area and Valuation its weakest.
What helps
- Quality & growth
- Sentiment Signal
What to watch
- Technical
- Valuation
- Risk
Quality & growth
30%82Strong
- Revenue growth 6.4%
- EPS growth -32.5%
Valuation
25%11Weak
- P/E 24.2
- EV/Sales 0.9
UnitedHealth Group is one of the largest private health insurers and provides medical benefits to about 51 million members globally, including 1 million outside the US as of December 2025. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in medical insurance. Along with its insurance assets, UnitedHealth's Optum franchises help create a healthcare services colossus that spans everything from pharmaceutical benefits to providing outpatient care and analytics to affiliates and third parties.
#35 by market cap in our coverage · ~390,000 employees · Listed 1984-10-17 · www.unitedhealthgroup.com
Price history
Intraday to five-year windows are free with an account
Members switch between 1D, 1M, 6M, 1Y, 2Y and 5Y and see the live price. Signed out, this is the one-year stored series the technicals below are computed from.
Market intelligence
Peer position
#103 / 139sector rank by TickerWhale Score
TickerWhale Score 48 vs sector average 55.1 (-7.1)
Revenue growth (industry)Top 75%
Gross margin (industry)Top 13%
Return on equity (industry)Top 38%
P/E (industry)Pricier than 67%
Technical analysis
our read · what classic indicators sayTickerWhale technical read
47/100Moderate vs universe
Ranks 47th of 100 covered names on our technical composite — the composite itself scores 46/100 · 25% of the TickerWhale Score
Classic chart indicators
Sell
2 buy · 5 sell · 1 neutral of 8 votes
TickerWhale rates UNH's technical setup middling — 47th percentile of the covered universe. Classic chart indicators lean sell — they read this stock on its own over days, where our score ranks it against every covered name over months, so the two often part company.
Moving averages
2 / 9constructive
- vs 200-day+6.4%
- vs 50-day-6.8%
Momentum
Mixed
- RSI (14)37 · neutral
- Stochasticbuy
- CCIsell
- Williams %Rbuy
Trend
Weak
- ADX (14) trend strength28· trending
- MACD (12,26,9)sell(histogram -1.425)
How the classic verdict is reached
Moving averages (9) agree on sell — 2 buy vs 7 sell — and carry one vote between them.
Oscillators (7) vote individually: 2 buy · 4 sell · 1 neutral.
Result — 2 buy vs 5 sell of 8 votes = Sell. Neutral votes never decide the verdict.
Fundamentals & valuation
2026-09-18 · revised_latestValuation multiples
- P/E (TTM)24.2
- P/S (TTM)0.8
- P/B3.5
- EV/EBITDA—
- EV/Sales0.9
- PEG—
Profitability & returns
- Gross margin30.8%
- Net margin3.1%
- ROE14.4%
- Debt/Equity0.74
Growth
- Revenue growth (YoY)6.5%
- EPS growth (YoY)-32.5%
Green favourable · red stretched — multiples and D/E vs industry peers, margins and growth vs absolute thresholds.
Market capitalisation — $341.5B
Fundamentals history
Reported statement totals across recent periods.
| Metric | Dec '25 | Dec '24 | Dec '23 |
|---|---|---|---|
| Revenue | $447.6B | $400.3B | $371.6B |
| Gross profit | $82.9B | $89.4B | $91.0B |
| Operating income | $19.0B | $32.3B | $32.4B |
| Net income | $12.1B | $14.4B | $22.4B |
| EPS (diluted) | $13.23 | $15.51 | $23.86 |
| Free cash flow | $16.1B | $20.7B | $25.7B |
| Cash | $24.4B | $25.3B | $25.4B |
| Total debt | $78.4B | $76.9B | $62.5B |
| Equity | $94.1B | $92.7B | $88.8B |
| Net debt | $54.0B | $51.6B | $37.1B |
| Debt / equity | 0.83 | 0.83 | 0.70 |
| Liabilities / assets | 0.67 | 0.66 | 0.64 |
Fundamentals are stored revised/latest (ADR-009): each period reflects the most recent vendor refresh, NOT point-in-time as-reported values. Do not use this series to claim what was known on a past date.
Model Target
Model Target is a Pro feature
Scores, factors and technicals stay free. The model's price target is part of TickerWhale Pro.
The Model Target is a TickerWhale Pro feature
A target exists for this name — the model priced it in the latest nightly run. Pro members see the target, its range and the methods behind it; one name's target is free every trading day.
Or see the current free one: MU →
Peers
| Company | Score | Pulse | P/E | P/E fwd | P/B | EV/Sales | Price | Chg | Estimate | Upside | Rev. gr. |
|---|---|---|---|---|---|---|---|---|---|---|---|
| UNHCurrentUnitedhealth Group | 48 | 46 | 24.2 | — | 3.5 | 0.9 | $376.90 | +0.45% | +6.5% | ||
| EXELExelixis | 81 | 80 | 17.6 | — | 8.2 | 6.1 | $58.36 | -0.22% | +9.2% | ||
| INCYIncyte | 81 | 76 | 16.2 | — | 4.1 | 3.8 | $125.31 | -1.81% | +26.9% | ||
| ACADAcadia Pharmaceuticals | 80 | 63 | 12.4 | — | 3.6 | 3.8 | $27.29 | -0.58% | +11.8% | ||
| OSCROscar Health Inc - | 78 | 67 | 19.5 | — | 5.2 | 0.5 | $32.13 | +0.47% | +43.1% | ||
| TGTXTG Therapeutics | 77 | 73 | 20.3 | — | 14.8 | 11.5 | $56.87 | +0.71% | +76.1% |
News, sentiment, the Street view and Ask Willy are free with an account
A free account shows the stories attached to this name, the Sentiment Signal breakdown, analyst consensus, the options read and the AI narration of the model output.